Sichuan Hebang Biotechnology Co., Ltd. (603077) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Sichuan Hebang Biotechnology Co., Ltd.

Why is Sichuan Hebang Biotechnology Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 8.42% and Operating profit at -181.26% over the last 5 years

The company has declared Negative results for the last 10 consecutive quarters

NET PROFIT(HY) At CNY 80.59 MM has Grown at -57.92%
INTEREST(HY) At CNY 58.84 MM has Grown at 33.21%
NET SALES(HY) At CNY 4,177.1 MM has Grown at -13.24%

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 50.27%, its profits have fallen by -125.3%
At the current price, the company has a high dividend yield of 1

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Chemicals & Petrochemicals)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Sichuan Hebang Biotechnology Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Sichuan Hebang Biotechnology Co., Ltd.

39.88%

1.24

40.59%

China Shanghai Composite

21.43%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

3.06%

EBIT Growth (5y)

-180.32%

EBIT to Interest (avg)

33.91

Debt to EBITDA (avg)

0.84

Net Debt to Equity (avg)

0.11

Sales to Capital Employed (avg)

0.33

Tax Ratio

2.14%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

12.99%

ROE (avg)

9.56%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.12

EV to EBIT

-83.07

EV to EBITDA

44.77

EV to Capital Employed

1.10

EV to Sales

3.29

PEG Ratio

Dividend Yield

ROCE (Latest)

-1.33%

ROE (Latest)

-2.69%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

14What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 1,155.29 MM

RAW MATERIAL COST(Y)

Fallen by -230.55% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 4.92 times

PRE-TAX PROFIT(Q)

Highest at CNY 207.89 MM

NET PROFIT(Q)

Highest at CNY 173.59 MM

EPS(Q)

Highest at CNY 0.02

-30What is not working for the Company

NET PROFIT(HY)

At CNY -395.68 MM has Grown at -123.12%

INTEREST(HY)

At CNY 67.68 MM has Grown at 98.47%

NET SALES(Q)

At CNY 1,387.81 MM has Fallen at -22.34%

ROCE(HY)

Lowest at -2.05%

DEBT-EQUITY RATIO (HY)

Highest at 12.47 %

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.35 times

Here's what is working for Sichuan Hebang Biotechnology Co., Ltd.

Pre-Tax Profit

At CNY 207.89 MM has Grown at 246.64%

over average net sales of the previous four periods of CNY -141.77 MM

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 173.59 MM has Grown at 245.83%

over average net sales of the previous four periods of CNY -119.04 MM

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (CNY MM)

Operating Cash Flow

Highest at CNY 1,155.29 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Pre-Tax Profit

Highest at CNY 207.89 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 173.59 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 0.02

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Debtors Turnover Ratio

Highest at 4.92 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -230.55% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Sichuan Hebang Biotechnology Co., Ltd.

Interest

At CNY 67.68 MM has Grown at 98.47%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Net Sales

At CNY 1,387.81 MM has Fallen at -22.34%

over average net sales of the previous four periods of CNY 1,787.13 MM

MOJO Watch

Near term sales trend is extremely negative

Net Sales (CNY MM)

Debt-Equity Ratio

Highest at 12.47 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Inventory Turnover Ratio

Lowest at 1.35 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio